Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage

Amin-Hanjani, 2001, Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice, Stroke, 32, 980, 10.1161/01.STR.32.4.980 Endres, 1998, Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)–CoA reductase inhibitors mediated by endothelial nitric oxide synthase, Proc Natl Acad Sci U S A, 95, 8880, 10.1073/pnas.95.15.8880 Gabikian, 2002, Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats, Stroke, 33, 2681, 10.1161/01.STR.0000033931.62992.B1 Goksel, 2001, Nitric oxide synthase inhibition attenuates vasoactive response to spinal cord stimulation in an experimental cerebral vasospasm model, Acta Neurochirurg, 143, 383, 10.1007/s007010170094 Haendler, 2004, Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells, Circulation, 110, 856, 10.1161/01.CIR.0000138743.09012.93 Harrod, 2005, Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review, Neurosurgery, 56, 633, 10.1227/01.NEU.0000156644.45384.92 Hernandez-Perera, 1998, Effects of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells, J Clin Invest, 101, 2711, 10.1172/JCI1500 Hoh, 2004, Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage, Neurosurgery, 55, 779, 10.1227/01.NEU.0000137628.51839.D5 Jung, 2004, HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage, Stroke, 35, 1744, 10.1161/01.STR.0000131270.45822.85 Laufs, 1998, Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors, Circulation, 97, 1129, 10.1161/01.CIR.97.12.1129 Lynch, 2005, Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial, Stroke, 36, 2024, 10.1161/01.STR.0000177879.11607.10 McGirt, 2006, Risk of cerebral vasospasm after subarachnoid hemorrhage reduced by statin therapy: a multivariate analysis of an institutional experience, J Neurosurg, 105, 671, 10.3171/jns.2006.105.5.671 McGirt, 2002, Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage, Stroke, 33, 2950, 10.1161/01.STR.0000038986.68044.39 Paiva, 2003, Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors, J Cardiovasc Pharmacol, 41, 219, 10.1097/00005344-200302000-00010 Parra, 2005, Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study, Neurosurgery, 56, 476, 10.1227/01.NEU.0000153925.96889.8A Pathak, 2003, Intermittent low dose intrathecal sodium nitroprusside therapy for treatment of symptomatic aneurysmal SAH-induced vasospasm, Br J Neurosurg, 17, 306, 10.1080/02688690310001601180 Pluta, 2005, Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment, Pharmacol Therapeut, 105, 23, 10.1016/j.pharmthera.2004.10.002 Pradilla, 2004, Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits, Neurosurgery, 55, 1393, 10.1227/01.NEU.0000143615.26102.1A Rabinstein, 2003, Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion, J Neurosurg, 98, 319, 10.3171/jns.2003.98.2.0319 Shishehbor, 2003, Statins promote potent systemic antioxidant effects through specific inflammatory pathways, Circulation, 108, 426, 10.1161/01.CIR.0000080895.05158.8B Singhal, 2005, SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage, Neurology, 64, 1008, 10.1212/01.WNL.0000154523.21633.0E Solenski, 1995, Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter cooperative aneurysm study, Crit Care Med, 23, 1007, 10.1097/00003246-199506000-00004 Thomas, 2002, Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting, Stroke, 33, 486, 10.1161/hs0202.103410 Thomas, 1999, Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans, Neurosurgery, 44, 48, 10.1097/00006123-199901000-00026 Tseng, 2005, Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneursmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial, Stroke, 36, 1627, 10.1161/01.STR.0000176743.67564.5d Wolfrum, 2003, Acute reduction of myocardial infarct size by hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase, J Cardiovasc Pharmacol, 41, 474, 10.1097/00005344-200303000-00017